Here’s how to choose a health insurance plan that fits your budget and life

Here’s how to choose a health insurance plan that fits your budget and life


Most Americans struggle to figure out which health insurance plan will save them money. It is a process that can be confusing, time-consuming and costly.

A study of almost 24,000 employees at a major Fortune 100 company found that 61% of them chose the wrong plan for their needs. The average employee could have saved an estimated $372 per year by choosing a different plan, according to the researchers at Carnegie Mellon University who conducted the study.

“The majority of employees chose plans that were more expensive, regardless of how much health care that they actually consumed the following year, and on average, the cost of these choices was about 2% of salary,” Carnegie Mellon associate professor of economics Saurabh Bhargava, who authored the study, told CNBC.

More from Invest in You:
How this risky strategy can leave retail investors vulnerable
Here’s how to invest your money if you are saving for your next vacation
5 money-saving tips from a TikTok lawyer who reads the fine print

In 2018, over 8% of Americans’ total household spending went toward health-care costs. This represents about a 37% increase since 2004, up from 5.9% of total household spending.

Forty-six percent of Americans say it’s difficult for them to pay the out-of-pocket costs for medical care not covered by their insurance, according to an October 2021 poll from the Kaiser Family Foundation.

“It seems like people aren’t able to maximize their welfare because they’re having trouble understanding the decision environment,” said Anya Samek, associate professor of economics at the Rady School of Management at the University of California, San Diego.

One major issue in choosing a health-care plan is people don’t understand the lingo insurance companies use to discuss each plan. Only about 1 in 3 people are able to correctly identify three common health insurance terms: premiums, copays and deductibles, according to Policygenius’ 2020 Health Insurance Literacy Survey. This lack of understanding is negatively impacting the pockets of Americans.

Watch the video above to learn why Americans struggle to pick the most financially beneficial insurance plan for them and how to avoid leaving money on the table.

SIGN UP: Money 101 is an 8-week learning course to financial freedom, delivered weekly to your inbox. For the Spanish version, Dinero 101, click here.

CHECK OUT: I generate thousands of dollars a month in passive income teaching online classes: Here’s how to get started with Acorns+CNBC

Disclosure: NBCUniversal and Comcast Ventures are investors in Acorns.



Source

Abortion pill makers brace for restrictions a year after Trump’s election
Health

Abortion pill makers brace for restrictions a year after Trump’s election

Mifepristone and Misoprostol pills are pictured Wednesday, Oct. 3, 2018, in Skokie, Illinois. Erin Hooley | Chicago Tribune | Tribune News Service | Getty Images Just over a year since Donald Trump was elected president again, the $6.9 billion abortion pill industry is operating under the same federal rules he inherited from former President Joe […]

Read More
Republicans push Obamacare tax credit alternatives as enrollment deadline looms
Health

Republicans push Obamacare tax credit alternatives as enrollment deadline looms

An Obamacare sign is displayed outside an insurance agency on Nov. 12, 2025 in Miami, Florida. Joe Raedle | Getty Images With enhanced Obamacare tax credits set to expire at the end of the year, Republicans are proposing new alternatives aimed at lowering the cost of health care. Their window for doing so is rapidly […]

Read More
Novo Nordisk shares plunge 10% after Alzheimer’s drug trial fails to hit key target
Health

Novo Nordisk shares plunge 10% after Alzheimer’s drug trial fails to hit key target

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg | Getty Images Shares of Novo Nordisk on Monday fell as much 11% after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer’s disease failed to meet its main goal. The trial tested whether semaglutide — the […]

Read More